Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-10-31

FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lithium carbonate from Hikma Pharmaceuticals USA Inc., signaling a regulatory change to the product (such as lab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE (LITHIUM CARBONATE)